XML 61 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net earnings $ 742.6 $ 445.6
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 398.1 373.9
Stock-based compensation expense 48.0 36.0
Change in estimated sales allowances 462.0 164.8
Deferred income tax benefit (250.5) (31.9)
Loss from equity method investments 65.5 13.1
Other non-cash items 120.3 90.8
Litigation settlements, net 47.2 (1.4)
Changes in operating assets and liabilities:    
Accounts receivable (339.2) (302.7)
Inventories (163.4) (177.3)
Trade accounts payable (126.8) 129.3
Income taxes 30.4 (8.4)
Other operating assets and liabilities, net (146.0) (43.1)
Net cash provided by operating activities 888.2 688.7
Cash flows from investing activities:    
Capital expenditures (220.3) (238.5)
Change in restricted cash (76.4) (49.0)
Cash paid for acquisitions, net (50.0) (50.9)
Proceeds from sale of property, plant and equipment 8.8 0
Purchase of marketable securities (17.6) (13.8)
Proceeds from sale of marketable securities 16.4 8.1
Payments for products rights and other, net (377.8) (19.1)
Net cash used in investing activities (716.9) (363.2)
Cash flows from financing activities:    
Payment of financing fees (2.4) (20.3)
Purchase of common stock 0 (500.0)
Change in short-term borrowings, net (75.1) 236.1
Proceeds from issuance of long-term debt 635.0 2,358.3
Payment of long-term debt (695.0) (2,457.3)
Proceeds from exercise of stock options 34.2 56.7
Taxes paid related to net share settlement of equity awards (22.8) 0
Payments for contingent consideration (150.0) 0
Other items, net 22.4 10.5
Net cash used in financing activities (253.7) (316.0)
Effect on cash of changes in exchange rates (9.3) 5.4
Net (decrease) increase in cash and cash equivalents (91.7) 14.9
Cash and cash equivalents — beginning of period 291.3 350.0
Cash and cash equivalents — end of period $ 199.6 $ 364.9